Learning Objectives
Upon completion of this program, you will be able to:
- Interpret the use of medicinal and recreational cannabis in Canada.
- Critique the evidence for the use of cannabis for the treatment of psychiatric disorders.
- Appraise the risks THC poses for the developing brain.
- Appraise the evidence concerning the impact of THC on the development of psychiatric disorders, including schizophrenia.
- Evaluate the pharmacological use of distinct psychedelics used in the treatment of psychiatric disorders.
Credits you'll earn

Speaker
Dr. Diane McIntosh
Clinical Assistant Professor, University of British Columbia
A widely respected author, educator, innovative entrepreneur, and advocate, she has dedicated her career to improving access to psychiatric care through the intersection of education and advanced technology. Dr. McIntosh has co-founded several landmark resources, including SwitchRx, an online tool used by over 125,000 global healthcare professionals; and RAPIDS, a platform designed to personalize psychiatric treatment and improve patient outcomes.
Beyond her clinical and digital innovation, she is the author of three books—including the acclaimed This is Depression—and the host of the PsychedUp, Blindsided, and Wicked Mind podcasts.
Dr. McIntosh’s significant contributions to Canadian healthcare and her lifelong service to psychiatric advocacy have earned her prestigious national recognitions. She was named one of Canada’s 100 Most Powerful Women by the Women’s Executive Network, and was honored with the King Charles III Coronation Medal, a testament to her enduring impact on medical education and her unwavering commitment to the mental health community.
Learn at Your Own Pace!
Enjoy 120 days of flexible access to review the material and claim your CME/CPD credits whenever it suits your schedule
-
Enroll Now
$125.00
Resident/Non-HCP
-
Enroll Now
$225.00
Physician
-
Enroll Now
$165.00
Pharmacist/Nurse Practitioner
-
Enroll Now
$145.00
Registered Nurse/Allied HCP